Powder absorbable hemostat market seen reaching $3.5 billion by 2030

The powder absorbable hemostat market is projected to grow from $2.48 billion in 2025 to $2.66 billion in 2026, with North America holding the largest share and Asia-Pacific set for the fastest growth. The report points to more surgeries, minimally invasive procedures and demand for faster bleeding control as the main drivers.

Why it matters: - Powder absorbable hemostats are used to control bleeding during surgery, so demand tracks closely with procedure volume and the need for safer outcomes. - Growth in the category signals continued spending on surgical tools that support rapid hemostasis, especially in delicate and minimally invasive operations. - The market’s expansion also reflects broader pressure on healthcare systems to reduce bleeding-related complications and improve patient safety.

What happened: - The Business Research Company released a market study on the powder absorbable hemostat market on August 25, 2026. - The market is projected to rise from $2.48 billion in 2025 to $2.66 billion in 2026, a 7.3% CAGR. - The report forecasts the market will reach $3.5 billion by 2030, growing at a 7.1% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region in the coming years. - A free sample of the report is available online. - The full market report is also available.

The details: - Powder absorbable hemostats are sterile, bioresorbable products designed to stop bleeding during surgery. - The products are made from plant- or animal-derived polysaccharides. - The powder format makes application easier on uneven or hard-to-reach surgical sites. - The main function is to absorb blood quickly and promote clot formation. - The market’s recent growth has been driven by more surgical procedures, greater awareness of blood-loss management, wider availability of collagen and gelatin-based materials, demand for rapid hemostasis and adoption of advanced surgical instruments. - Future growth is expected to be supported by innovations in powder hemostat formulas, more minimally invasive surgeries, growth in ambulatory surgical centers, an aging population and higher healthcare spending. - The report highlights trends including biocompatible and bioresorbable materials, customizable powder formulations and rising outpatient surgical procedures. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The market forecast suggests bleeding control products are becoming more specialized as surgery shifts toward less invasive techniques and faster recovery settings. - The emphasis on customizable formulations points to demand for products that can fit different procedure types and surgical environments. - A March 2023 report from the British Association of Aesthetic Plastic Surgeons said 31,057 cosmetic surgeries were performed in the UK in 2022, up 102% from the prior year, illustrating how higher procedure volumes can feed demand for hemostatic products.

What's next: - The report expects continued adoption of minimally invasive surgical methods to support powder absorbable hemostat demand. - Growth in ambulatory and outpatient surgery is likely to keep pushing suppliers toward faster, easier-to-apply bleeding control solutions. - Regional growth is expected to stay strongest in Asia-Pacific as the market broadens beyond North America.

The bottom line: - Powder absorbable hemostats are moving from a niche surgical aid to a growing category tied to broader shifts in how and where surgery is performed.